Entropy | Free Full-Text | Escalation with Overdose Control is More Efficient and Safer than Accelerated Titration for Dose Finding
Exposure driven dose escalation design with overdose control: Concept and first real life experience in an oncology phase I trial - ScienceDirect
Study design for dose-escalation cohorts and DLT rate (as calculated by... | Download Scientific Diagram
Determining drug dose in the era of targeted therapies: playing it (un)safe? | Blood Cancer Journal
Adaptive designs for dual-agent phase I dose-escalation studies | Nature Reviews Clinical Oncology
On Biostatistics and Clinical Trials: Dose Limiting Toxicity (DLT) and Common Toxicity Criteria (CTC) / Common Terminology Criteria for Adverse Events (CTCAE)
Dose-Finding Schemes in Clinical Trials
Early phase clinical trials to identify optimal dosing and safety - Cook - 2015 - Molecular Oncology - Wiley Online Library
Three-plus-three dose escalation design. DLT, dose-limiting toxicity;... | Download Scientific Diagram
1. Given the true DLT rate, calculate the probability | Chegg.com
Dose Limiting Toxicities (DLT) DOSE LIMITING TOXICITIES (DLT) Example: Dose escalation will proceed within each cohort according
Recommended dosages in each arm. DLT, dose-limiting toxicity; RD,... | Download Scientific Diagram
Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin study - ScienceDirect
Flexibility of the BLRM in Dose-Escalation Trials
Study flow chart. DLT, dose-limiting toxicity. | Download Scientific Diagram
A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia | PLOS ONE
1. In a typical Phase I clinical trial of a new drug, | Chegg.com
Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin study. - Abstract - Europe PMC
Illustration of the chronic dose-limiting toxicity (DLT) concept. (*)... | Download Scientific Diagram
Practical Model-based Approaches for Phase I Oncology Trial
Single-arm, open-label, dose-escalation phase I study to evaluate the safety of a herbal medicine SH003 in patients with solid cancer: a study protocol | BMJ Open
Study protocol: phase 1 dose escalating study of Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasis
Dose escalation algorithm for trial part 1. DLT, dose-limiting... | Download Scientific Diagram
DURVIT': a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment | BMC Cancer | Full Text
Outline
Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer | BMC Cancer | Full Text
